Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine

NCT01667341 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

143

Enrollment

INDUSTRY

Sponsor class

Conditions

Genital Herpes Simplex Type 2

Interventions

BIOLOGICAL: GEN-003 with Matrix M-2
BIOLOGICAL: GEN-003
BIOLOGICAL: Placebo

Sponsor

Genocea Biosciences, Inc.